Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +18.6K | 39.0K | +91% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $11.24 | -5,452 | 35.5K | -13% | -$61.3K |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -18.6K | 13.1K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-03-16 | M | A | 6,569 | — | 28,965 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2023-03-16 | F | D | 1,929 | $11.46 | 27,036 | D | — | — | |
| 3 | Common | Class A Common Share | 2023-03-20 | M | A | 12,002 | — | 39,038 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 4 | Common | Class A Common Share | 2023-03-20 | F | D | 3,523 | $11.12 | 35,515 | D | — | — | |
| 5 | Derivative | Restricted Share Unit | 2023-03-20 | M | D | 12,002 | $0.00 | 0 | D | — · — to — | 12,002 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2023; there was no expiration date for the RSUs. |
| 6 | Derivative | Restricted Share Unit | 2023-03-16 | M | D | 6,569 | $0.00 | 13,138 | D | — · — to — | 6,569 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. |